Goralatide Peptide

In tumor treatment, chemotherapeutic drugs (such as doxorubicin) and radiotherapy are conventional therapies. However, these treatments lack specificity. While killing tumor cells, they cause severe damage to normal hematopoietic stem cells and myeloid progenitor cells, triggering adverse reactions such as myelosuppression and decreased immunity, and may even lead to treatment interruption in severe cases.As a physiological regulator of hematopoietic function, goralatide peptide inhibits the entry of murine and human hematopoietic stem cells into the S phase, reducing damage to specific bone marrow cell populations induced by chemotherapy and radiotherapy. It has become an important research direction for tumor adjuvant therapy.

In terms of chemotherapy toxicity protection, multiple in vivo experiments have confirmed that Goralatide can effectively reduce doxorubicin-induced toxicity and improve the survival rate of experimental mice.

Studies show that at a daily dose of 2.4 g, administered via continuous subcutaneous infusion or divided subcutaneous injection starting 48 hours prior to doxorubicin treatment for 3 consecutive days, Goralatide can significantly lower the mortality rate of mice caused by doxorubicin. Meanwhile, it specifically protects long-term repopulating cells (LTRCs), spleen colony-forming units, high-proliferative potential colony-forming cells, and colony-forming unit-granulocyte macrophage (CFU-GM) in the bone marrow, alleviating doxorubicin-induced damage to these key hematopoietic cells.In addition, combined use of Goralatide with granulocyte colony-stimulating factor (G-CSF) further optimizes the recovery of the CFU-GM population and accelerates the repair of hematopoietic function after chemotherapy. This improves the therapeutic index of chemotherapeutic drugs and ensures that tumor patients can complete the full course of treatment.

In hyperthermia adjuvant therapy, Goralatide modulates the thermal sensitivity of hematopoietic progenitor cells and enhances the selectivity of hyperthermia in purifying human progenitor cells. Research indicates that Goralatide reduces the thermal sensitivity of normal hematopoietic progenitor cells while widening the thermal sensitivity difference between leukemic progenitor cells and normal ones. It broadens the inhibitory window of hyperthermia against leukemic cells, minimizes damage to normal hematopoietic cells during hyperthermia, and provides a novel adjuvant strategy for hyperthermia treatment of hematological malignancies such as leukemia.

With the rapid development of the medical aesthetics industry, natural peptides have become core anti-aging skincare ingredients due to their mild efficacy, high efficiency and safety profile. As a natural tetrapeptide, Goralatide has recently been found to exert anti-skin and anti-hair aging effects. Its anti-aging mechanisms are mainly related to regulating cell metabolism, protecting skin stem cells and inhibiting oxidative damage, and it has been gradually applied in skincare and hair care products.

In skin anti-aging, Goralatide preserves the vitality of skin stem cells and delays skin aging. Skin stem cells are pivotal for maintaining skin metabolism and repairing skin damage.

With aging, the proliferative capacity of skin stem cells declines, leading to skin sagging, wrinkle formation and reduced elasticity. By regulating the cell cycle, goralatide peptide inhibits excessive proliferation and senescence of skin stem cells and maintains their self-renewal ability. It also boosts the synthesis of skin collagen and elastic fibers, improves skin sagging and fine lines, and enhances skin firmness and radiance. In addition, it suppresses oxidative stress, reduces free radical damage to skin cells, delays skin photoaging, and mitigates ultraviolet-induced skin damage.In hair care, Goralatide promotes the proliferation and differentiation of hair follicle stem cells and improves problems such as sparse hair and alopecia.

Declined vitality of hair follicle stem cells is one of the main causes of hair loss and dry hair. Goralatide regulates the metabolism of hair follicle stem cells, enhances their proliferative capacity, facilitates hair follicle repair and hair regeneration, and optimizes nutrient supply to hair, making hair denser and shinier. Currently, Goralatide has been added into shampoos, conditioners and hair growth essences as an innovative active ingredient for hair care.

Featuring natural origin and low irritation, Goralatide is suitable for all skin types, especially sensitive skin and mature skin. Its application prospects in medical aesthetic anti-aging are expanding steadily, with continuous progress in the research, development and promotion of related products.